Ingredient
Butylphthalimide
Butylphthalimide is flagged for pregnancy, breastfeeding, trying to conceive and PCOS. The concern behind the strongest flag is hormone disruptor and absorbed into the body.
- N-Butylphthalimide
- 2-Butylphthalimide
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 4 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Butylphthalimide and pregnancy
Caution Advised
- Hormone disruptor
- Absorbed into the body
Butylphthalimide is a synthetic compound with structural similarities to phthalates, a class of chemicals that have raised concerns in reproductive health. While not a true phthalate, the phthalimide structure shares chemical characteristics that warrant cautious evaluation. The concern during pregnancy stems from the established research on phthalates, which are known endocrine disruptors. According to ACOG, certain phthalates can interfere with hormone function and have been associated with adverse reproductive outcomes. While specific studies on butylphthalimide in pregnancy are limited, the structural relationship to problematic compounds suggests a precautionary approach is warranted. The potential for systemic absorption and hormone-like activity has not been fully characterized. Due to insufficient safety data specific to pregnancy and the compound's relationship to concerning chemical classes, many experts recommend avoiding ingredients with uncertain profiles during pregnancy when safer alternatives exist. This represents a precautionary stance rather than confirmed harm.
Butylphthalimide and breastfeeding
Caution Advised
- Passes into breast milk
Butylphthalimide's chemical structure suggests potential for systemic absorption if used topically, though specific data on dermal penetration and pharmacokinetics is limited. Related phthalate compounds are known to be lipophilic, raising theoretical concerns about transfer into breast milk. While there is no direct evidence of butylphthalimide transfer into breast milk, the chemical family's characteristics suggest caution. Related compounds can accumulate in fatty tissues and potentially transfer to breastfed infants. Given the lack of safety studies specific to lactation, many healthcare providers recommend avoiding ingredients with uncertain profiles. The limited safety data for breastfeeding populations, combined with the availability of well-studied alternatives, supports a precautionary approach. Until more comprehensive research establishes safety, limiting exposure to compounds with unknown lactation profiles is reasonable.
Butylphthalimide and postpartum
Safe to Use
- Irritant
For postpartum women who are not breastfeeding, the primary concerns with butylphthalimide are limited to potential skin irritation rather than systemic effects. The ingredient may cause sensitivity in some individuals, particularly on recovering or stressed skin. Without the concern of infant exposure through breast milk, the risk profile is lower. However, the limited safety data and potential for irritation suggest cautious use, especially on sensitive postpartum skin. Better-studied ingredients with established safety profiles may be preferable during this recovery period.
Butylphthalimide and trying to conceive
Caution Advised
- Hormone disruptor
Women trying to conceive should be mindful of potential endocrine-disrupting exposures, as hormonal balance is critical for fertility. Butylphthalimide's structural similarity to phthalates, which are associated with reproductive health concerns, warrants caution during preconception. While there is no direct evidence that topical butylphthalimide affects fertility, the precautionary principle suggests limiting exposure to ingredients with uncertain hormonal effects when trying to conceive. Optimizing hormonal balance and minimizing potential disruptors can support fertility efforts. Consider switching to products with well-established safety profiles during this critical time.
Butylphthalimide and PCOS
Caution Advised
- Interferes with hormones
Butylphthalimide's structural relationship to phthalates raises theoretical concerns for women with PCOS, a condition characterized by hormonal imbalances. Phthalates are known endocrine disruptors that can interfere with reproductive hormones. Women with PCOS already experience hormonal dysregulation, making them potentially more vulnerable to additional endocrine-disrupting exposures. While specific research on butylphthalimide and PCOS is lacking, the established effects of related compounds on androgen and estrogen pathways suggest caution. Given the uncertainty around this ingredient's hormonal effects and the availability of alternatives without endocrine-disrupting potential, women with PCOS may choose to avoid products containing butylphthalimide as a precautionary measure. Focus on well-studied ingredients that don't interfere with hormone balance is advisable for PCOS management.
Butylphthalimide and general use
Safe to Use
- Irritant
- Common allergen
Butylphthalimide is used in some cosmetic formulations, though its prevalence and specific functions are not well-documented in mainstream cosmetic chemistry. The ingredient's safety profile for general use is not as extensively studied as more common cosmetic ingredients. For the general population without pregnancy or hormonal concerns, the primary considerations are potential skin irritation and allergic reactions. Some individuals may experience sensitivity to phthalimide compounds, manifesting as redness, itching, or contact dermatitis. The ingredient's irritancy potential appears mild to moderate based on its chemical structure. While not explicitly restricted by major regulatory bodies, the limited safety data and structural relationship to concerning compounds makes it a less-than-ideal choice when better-studied alternatives are available. Individuals seeking to minimize exposure to ingredients with uncertain profiles may choose to avoid it, though it likely poses minimal risk to most users when used as intended in cosmetic formulations.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Butylphthalimide, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store